Sebaceous carcinoma is an uncommon malignant neoplasm of the sebaceous glands, with an estimated incidence of 1 in 1,000,000 people per year. 1 The sebaceous glands are normally found in hair ...

(RTTNews) - Pulse Biosciences, Inc. (PLSE), a bioelectric medicine company, has received FDA clearance for its CellFX System to expand the indication for use in the treatment of sebaceous hyperplasia ...

HAYWARD, Calif.-- (BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) today announced treatment of the first patients in its multicenter study to evaluate the safety and efficacy of its Nano-Pulse ...

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company developing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

(HealthDay News) – Laser treatments targeting the sebaceous glands may potentially be used for the treatment of acne, according to a study published in the February issue of Lasers in Surgery and ...

Please provide your email address to receive an email when new articles are posted on . Mismatch repair (MMR) screening showed MMR deficiency in one-third of sebaceous carcinoma (SC) cases. Rates of ...